a randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic profiles of cigarettes and e-cigarettes with nicotine salt formulations in US adult smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
O'Connell (2019)
E-Cigarette Use and Subsequent Cigarette Initiation and Sustained Use among Youth, U.S., 2015-2017.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Odani (2020)
Particle size distribution of selected electronic nicotine delivery system products
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Oldham (2018)
Longitudinal investigation of the bidirectional associations between initiation of e-cigarettes and other substances in adolescents.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Ortega (2021)
E-cigarette Transitions among US Youth and adults: Results from the Population assessment of Tobacco and health Study (2013-2018).
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Osibogun (2022)
adolescent E-cigarette Users at highest Risk of Cigarette Smoking Intention.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Owotomo (2021)
Smoking Intention and Progression From E-Cigarette Use to Cigarette Smoking.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Owotomo (2020)
history repeats itself: Role of characterizing flavors on nicotine use and abuse.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Patten (2020)
Exposure to fruit-flavoring during adolescence increases nicotine consumption and promotes dose escalation.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Patten (2021)
The interactive effects of JUUL flavor and nicotine concentration on addiction potential.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Peasley-Miklus (2023)